Effect of cholesterol-rich diets with and without added vitamins E and C on the severity of atherosclerosis in rabbits

American Journal of Clinical Nutrition

Volumn 66, Issue 5, 1997, Pages 1240-1249

  Mahfouz, Mohamedain M ^b   Kawano, Hiroshige ^b   Kummerow, Fred A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b NONE

Author keywords

Antioxidant; Atherosclerosis; Cholesterol oxides; Hypercholesterolemia; Rabbits; Vitamin C; Vitamin E

Indexed keywords

25 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; 7 OXOCHOLESTEROL; 7ALPHA HYDROXYCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; ALPHA TOCOPHEROL; ASCORBIC ACID; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MALONALDEHYDE; MEMBRANE PROTEIN; STEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE SEVERITY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERCHOLESTEROLEMIA; LIVER MEMBRANE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; RABBIT;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0030836216     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/66.5.1240     Document Type: Article

References (61)

1. Kosykh VA, Lankin VZ, Poderz EA, et al. Very low density lipoprotein secretion by cultured hepatocytes of rabbits fed purified or autoxidized cholesterol. Lipids 1989;24:109-15.
2. Brown MS, Dana SE, Goldstein JL. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins. Proc Natl Acad Sci U S A 1973;70:2162-6.
3. Fogelman AM, Edmond J, Seager J, Popjak G. Abnormal induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase in leukocytes from subjects with heterozygous familial hypercholesterolemia. J Biol Chem 1975;250:2045-55.
4. Beirne OR, Watson JA. Comparison of regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in hepatoma cells grown in vivo and in vitro. Proc Natl Acad Sci U S A 1976;73:2735-9.
5. Kandutsch AA, Chen HW. Inhibition of sterol synthesis in cultured mouse cells by 7α-hydroxycholesterol, 7β-hydroxycholesterol, and 7-ketocholesterol. J Biol Chem 1973;248:8408-17.
6. Kandutsch AA, Chen HW. Inhibition of sterol synthesis in cultured mouse cells by cholesterol derivatives oxygenated in the side chain. J Biol Chem 1974;249:6057-61.
7. Chen HW, Kandutsch AA, Waymouth C. Inhibition of cell growth by oxygenated derivatives of cholesterol. Nature 1974;251:419-21.
8. Boissonneault GA, Hennig B, Wang Y, et al. Effect of oxysterol-enriched low density lipoprotein on endothelial barrier function in culture. Ann Nutr Metab 1991;35:226-32.
9. Zwijsen RML, Oudenhoven IMJ, De Haan LHJ. Effect of cholesterol and oxysterols on gap junctional communication between human smooth muscle cells. Eur J Pharmacol 1992;228:115-20.
10. Allain CA, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
11. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for high density lipoprotein cholesterol. Clin Chem 1982;28:1379-88.
12. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973;19:476-82.
13. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new calorimetric method. Clin Chim Acta 1978;90:37-43.
14. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497-509.
15. Eng LF, Noble EP. The maturation of rat brain myelin. Lipids 1968;3:157-162.
16. Roe JH, Kuether CA. The determination of ascorbic acid in whole blood and urine through the 2,4-dinitro-phenylhydrazine derivative of dehydroascorbic acid. J Biol Chem 1943:147:399-407.
17. Zak B, Dickenman RC, White EG, Burnett H, Cherney PJ. Rapid estimation of free and total cholesterol. Am J Clin Pathol 1954;24:1307-15.
18. Pinter JK, Hayashi JA, Watson JA. Enzymatic assay of glycerol, dihydroxyacetone and glyceraldehyde. Arch Biochem Biophys 1967;121:404-7.
19. Mahfouz MM, Zhou Q, Kummerow FA. Cholesterol oxides in plasma and lipoproteins of magnesium-deficient rabbits and effects of their lipoproteins on endothelial barrier function. Magnes Res 1994;7:207-22.
20. Ferreri LF. Fractionation of plasma lipoprotein. In: Story JA, ed. Lipid research methodology. New York: Alan R Liss, 1984:134-41.
21. Roach PD, Zollinger M, Noel SP. Detection of the low density lipoprotein (LDL) receptor on nitrocellulose paper with colloidal gold-LDL conjugates. J Lipid Res 1987;28:1515-21.
22. Kovanen PT, Brown MS, Goldstein JL. Increased binding of LDL to liver membranes from rats treated with 17α-ethinyl estradiol. J Biol Chem 1979;254:11367-73.
23. Roach PD, Noel SP. Solubilization of the 17α-ethinyl estradiol-stimulated low density lipoproteins receptor of male rat liver. J Lipid Res 1985;26:713-20.
24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
25. Wu C-C, Chang S-W, Chen M-S, Lee Y-T. Early change of vascular permeability in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol 1995;15:529-33.
26. Cayatte AJ, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 1994;14:753-9.
27. Analysis of variance. In: Choi SC, ed. Introductory applied statistics in science. Englewood Cliffs, NJ: Prentice-Hall, Inc, 1978:191-223.
28. Schwenck E, Stevens DF, Altschul R. Experiments on cholesterol atherosclerosis in rabbits. Proc Soc Exp Biol Med 1959;102:42-5.
29. Higley NA, Beery JT, Taylor SL, Porter JW, Dziuba JA, Lalich JJ. Comparative atherogenic effects of cholesterol and cholesterol oxides. Atherosclerosis 1986;62:91-104.
30. Roth RI, Ganbatz JW, Gotto AM, Patsch JR. Effect of cholesterol feeding on the distribution of plasma lipoproteins and on the metabolism of apoprotein E in the rabbits. J Lipid Res 1983;24:1-14.
31. Mackinnon AM, Savage J, Gibson RA, Barter PJ. Secretion of cholesterol ester-enriched very low density lipoproteins by the liver of cholesterol-fed rabbits. Atherosclerosis 1985;54:145-55.
32. Kovanen PT, Brown MS, Basu SK, Bilheimer DW, Goldstein JL. Saturation and suppression of hepatic lipoprotein receptors; a mechanism for the hypercholesterolemia of cholesterol-fed rabbits. Proc Natl Acad Sci U S A 1981;78:1396-400.
33. Kumar NS, Abraham R, Kumar GS, Sudhakaran PR, Kurup PA. Synthesis and secretion of VLDL by rat hepatocytes-modulation by cholesterol and phospholipids. Indian J Biochem Biophys 1992;29:438-41.
34. Kubaska WM, Gurley EC, Hylemon PB, Guzelian PS, Vlahcevic ZR. Absence of negative feedback control of bile acid biosyntheses in cultured rat hepatocytes. J Biol Chem 1985;260:13459-63.
35. Simon JA. Vitamin C and cardiovascular disease: a review. J Am Coll Nutr 1992;11:107-25.
36. Goldstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Am Rev Biochem 1977;46:897-930.
37. Dietschy JM, Wilson JD. Regulation of cholesterol metabolism. N Engl J Med 1970;282:1128-38,1179-83,1241-9.
38. Gudmundsen O, Berg T, Roos N, Nenseter MS. Hepatic uptake of β-VLDL in cholesterol-fed rabbits. J Lipid Res 1993;34:589-600.
39. Feeney RE, Blankkenhorn G, Dixon HBF. Carbonyl-amine reactions in protein chemistry. Adv Protein Chem 1975;29:135-203.
40. McCall MR, Tang JY, Bielicki JK, Forte TM. Inhibition of lecithin-cholesterol acyltransferase and modification of HDL apolipoproteins by aldehydes. Arterioscler Thromb Vase Biol 1995;15:1599-606.
41. Dobrian A, Mora R, Simionescu M, Simionescu N. In vitro formation of oxidatively-modified and reassembled human low-density lipoproteins: antioxidant effect of albumin. Biochim Biophys Acta 1993;1169:12-24.
42. Kikugawa K, Beppu M, Okamoto Y. Uptake by macrophages of low-density lipoprotein damaged by nitrogen dioxide in air. Lipids 1995;30:313-20.
43. Mahfouz MM, Hulea SA, Kummerow FA. Cigarette smoke increases cholesterol oxidation and lipid peroxidation of human low density lipoprotein and decreases its binding to the hepatic receptor in vitro. J Environ Pathol Toxicol Oncol 1995;14:181-92.
44. Fogelman AM, Shechter I, Seager J, Hokom M, Child JS, Edwards PA. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci U S A 1980;77:2214-8.
45. Mahley RW, Innerarity TL, Brown MS, Ho YK, Goldstein JL. Cholesteryl ester synthesis in macrophages: stimulation by β-VLDL from cholesterol fed animals of several species. J Lipid Res 1980;21:970-80.
46. Fainaru M, Funke H, Boyles JK, Ludwig EH, Innerarity TL, Mahley RW. Metabolism of canine β-very low density lipoproteins in normal and cholesterol-fed dogs. Arteriosclerosis 1988;8:130-9.
47. Panasenko OM, Sdvigova AG, Sergienko VI, Lopukhin Y-M. The rabbit liver in experimental atherosclerosis secretes oxidized lipoproteins. Byulleten Eksperimental'noi Biologii i Meditsiny 1992;113:181-3.
48. Sulyok S, Bar-Pollak Z, Feher E, Kemenes I, Kantor I, Feher J. Liver lipid peroxidation induced by cholesterol and its treatment with a dihydroquinoline type free radical scavenger in rabbits. Acta Physiol Hung 1984;64:437-42.
49. Bulur H, Gokkusa C, Uysal M. Erthyrocyte lipid peroxidation and anemia in cholesterol-fed rabbits. Nutr Rep Int 1986;33:247-51.
50. Parthasarathy S, Quinn MT, Schwenke DC, Carew TE, Steinberg D. Oxidative modification of β-VLDL. Arteriosclerosis 1989;9:398-404.
51. Palinski W, Rosenfeld ME, Yla-Hettuala S, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A 1989;86:1372-6.
52. Nenseter MS, Gudmundsen O, Malterud KE, Berg T, Drevon CA. Effect of cholesterol feeding on the susceptibility of lipoproteins to oxidative modification. Biochim Biophys Acta 1994;1213:207-14.
53. Peng SK, Phillips GA, Guang-Zhi X, Morin RJ. Transport of cholesterol autoxidation products in rabbit lipoproteins. Atherosclerosis 1987;64:1-6.
54. Smith LL, Johnson BH. Biological activities of oxysterols. Free Radic Biol Med 1989;7:285-32.
55. Hodis NH, Chauhan A, Hashimoto S, Crawford DW, Sevanian A. Probucol reduces plasma and aortic wall oxysterols level in cholesterol fed rabbits independently of its plasma cholesterol lowering effect. Atherosclerosis 1992;96:125-34.
56. Stalenheof AFH, Kleiveld HA, Kosmeijer-Schil TG, Demacker PNM, Katan MB. In vivo oxidized cholesterol in atherosclerosis. Atherosclerosis 1993;98:113-4.
57. Smith LL. Another cholesterol hypothesis:cholesterol as antioxidant. Free Radic Biol Med 1991;11:47-61.
58. Peng SK, Taylor CB. Atherogenic effects of oxidized cholesterol. In: Perkins EG, Wisek WJ, eds. Dietary fats and health. Champaign, IL: American Oil Chemists Society, 1983:919-33.
59. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of low density lipoprotein. Free Radic Biol Med 1992;13:341-90.
60. Godfried SL, Combs GF, Saroka JM, Dillingham LA. Potentiation of atherosclerotic lesions in rabbits by a high dietary level of vitamin E. Br J Nutr 1989;61:607-17.
61. Stocker R, Thomas SR, Upston JM, Neuzil J. Tocopherol-mediated lipid peroxidation of isolated LDL and human plasma exposed to various radical oxidants. Atherosclerosis 1995;115(suppl):A152 (abstr).